Walter C. Ogier
Directeur/Membre du Conseil chez ELEDON PHARMACEUTICALS, INC.
Fortune : 11 532 $ au 30/04/2024
Profil
Walter C.
Ogier was the founder of Acetylon Pharmaceuticals, Inc. founded in 2008, where he held the position of President & Director until 2016.
He currently holds director positions at Biothera, Inc., Thetis Pharmaceuticals LLC, and Eledon Pharmaceuticals, Inc. He was also Chairman at Anelixis Therapeutics, Inc. and Vice President-Marketing at Vericel Corp.
Mr. Ogier has an undergraduate degree from Williams College and an MBA from Yale School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/05/2023 | 5 709 ( 0,02% ) | 11 532 $ | 30/04/2024 |
Postes actifs de Walter C. Ogier
| Sociétés | Poste | Début |
|---|---|---|
| ELEDON PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 14/09/2020 |
Thetis Pharmaceuticals LLC
 Thetis Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Thetis Pharmaceuticals LLC is a biopharmaceutical company. It improves the lives of patients suffering from gastrointestinal diseases. The company’s proprietary HEALER™ technology platform enables the pharmaceutical development of bioactive lipids, including resolving and other fatty acids, that actively regulate inflammation resolution and tissue repair. Its technologies are pro-resolving lipids and intellectual property. The company was founded by Frank C. Sciavolino, Banavara L. Mylari and Gary Mathias in 2011 and is headquartered in Southport, CT. | Directeur/Membre du Conseil | 01/01/2016 |
Biothera, Inc.
 Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | Directeur/Membre du Conseil | - |
Anciens postes connus de Walter C. Ogier
| Sociétés | Poste | Fin |
|---|---|---|
Nemucore Medical Innovations, Inc.
 Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Directeur/Membre du Conseil | 01/04/2022 |
Anelixis Therapeutics, Inc.
 Anelixis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Anelixis Therapeutics, Inc. operates as a clinical stage, privately held biotechnology company. It develops treatments for patients with neurodegenerative disease, people requiring an organ or cell based transplant, as well as people with an autoimmune disease. The company was founded by Steve Perrin in 2015 and is headquartered in Cambridge, MA. | Président | 01/09/2020 |
Biothera Pharmaceutical, Inc.
 Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | Directeur/Membre du Conseil | 01/09/2020 |
Regenacy Pharmaceuticals LLC
 Regenacy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Regenacy Pharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It develops treatments for diabetic and peripheral neuropathies. The firm provides treatments through regeneration of normal protein function using oral, isoform selective histone deacetylase enzyme inhibitors. It provides treatment for diseases such as sickle cell disease, ß-thalassemia, leukemia, and cognitive dysfunction in neurological disorders. The company was founded by Marc A. Cohen in December 2016 and is headquartered in Waltham, MA. | Directeur Général | 01/03/2020 |
IRX Therapeutics, Inc.
 IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology IRX Therapeutics, Inc. provides pharmaceutical products. Its therapies are designed to target and restore the immune system in order to improve a patient's response to next-generation cancer vaccines and novel targeted therapeutics. The company was founded in 1994 and is headquartered in New York, NY. | Directeur/Membre du Conseil | 01/11/2018 |
Formation de Walter C. Ogier
| Williams College | Undergraduate Degree |
| Yale School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| VERICEL CORPORATION | Health Technology |
| ELEDON PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 13 |
|---|---|
SRI International
 SRI International Miscellaneous Commercial ServicesCommercial Services SRI International provides contract research and development services. It is an independent, nonprofit research institute conducting client-sponsored research and development for government agencies, commercial businesses, foundations, and other organizations. The company was founded in 1946 and is headquartered in Menlo Park, CA. | Commercial Services |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
AccuMed, Inc.
 AccuMed, Inc. Pharmaceuticals: MajorHealth Technology AccuMed, Inc. develops and manufactures pharmaceutical tablets, powders, liquids and edible breath strip products. The company's products are used for laxative, gas relief, stomach remedies, nasal and throat sprays and oral care. It supplies products to retail chains throughout the drug store, food store and mass merchandise, convenience store and wholesale markets The company was founded by Peter P. Gombrich in February, 1994 and is headquartered in Lawrenceville, NJ | Health Technology |
Arbios Systems, Inc.
 Arbios Systems, Inc. Medical SpecialtiesHealth Technology Arbios Systems, Inc. engages in the development, manufacture, and marketing of liver assist therapies for medical treatment of liver failure. The company was founded by Achilles A. Demetriou and Jacek Rozga in February 1999 and is headquartered in Allendale, NJ. | Health Technology |
Acetylon Pharmaceuticals, Inc.
 Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | Health Technology |
Eligix, Inc.
 Eligix, Inc. Medical/Nursing ServicesHealth Services Eligix, Inc. develops and distributes medicines. It also offers cellular transplantation and immune therapies to enhance human immune response to cancers and infectious diseases. The company is located in Medford, MA | Health Services |
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | Commercial Services |
Thetis Pharmaceuticals LLC
Thetis Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Thetis Pharmaceuticals LLC is a biopharmaceutical company. It improves the lives of patients suffering from gastrointestinal diseases. The company’s proprietary HEALER™ technology platform enables the pharmaceutical development of bioactive lipids, including resolving and other fatty acids, that actively regulate inflammation resolution and tissue repair. Its technologies are pro-resolving lipids and intellectual property. The company was founded by Frank C. Sciavolino, Banavara L. Mylari and Gary Mathias in 2011 and is headquartered in Southport, CT. | Health Technology |
Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Health Technology |
Biothera Pharmaceutical, Inc.
Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | Health Services |
Anelixis Therapeutics, Inc.
Anelixis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Anelixis Therapeutics, Inc. operates as a clinical stage, privately held biotechnology company. It develops treatments for patients with neurodegenerative disease, people requiring an organ or cell based transplant, as well as people with an autoimmune disease. The company was founded by Steve Perrin in 2015 and is headquartered in Cambridge, MA. | Health Technology |
Regenacy Pharmaceuticals LLC
Regenacy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Regenacy Pharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It develops treatments for diabetic and peripheral neuropathies. The firm provides treatments through regeneration of normal protein function using oral, isoform selective histone deacetylase enzyme inhibitors. It provides treatment for diseases such as sickle cell disease, ß-thalassemia, leukemia, and cognitive dysfunction in neurological disorders. The company was founded by Marc A. Cohen in December 2016 and is headquartered in Waltham, MA. | Health Technology |
IRX Therapeutics, Inc.
IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology IRX Therapeutics, Inc. provides pharmaceutical products. Its therapies are designed to target and restore the immune system in order to improve a patient's response to next-generation cancer vaccines and novel targeted therapeutics. The company was founded in 1994 and is headquartered in New York, NY. | Health Technology |
